Beijing Centergate Technologies (Holding) Co., Ltd. (000931.SZ) Has 34 Products Included in National Reimbursement Drug List

Stock News12-12 16:24

Beijing Centergate Technologies (Holding) Co., Ltd. (000931.SZ) announced that some drugs developed by its subsidiaries have been included in the National Reimbursement Drug List (NRDL) for 2025. The company's wholly-owned subsidiary, Beijing Zhongguancun Sihuan Pharmaceutical Development Co., Ltd. (Sihuan Pharmaceutical), along with its controlled subsidiaries—Beijing Huasu Pharmaceutical Co., Ltd. (Beijing Huasu), Shandong Huasu Pharmaceutical Co., Ltd. (Shandong Huasu), and Duoduo Pharmaceutical Co., Ltd. (Duoduo Pharmaceutical)—have collectively secured 34 in-production products in the 2025 NRDL.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/1108769445?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-12-12 16:24","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1108769445","market":"nz","top_or_hot":-1,"title":"Beijing Centergate Technologies (Holding) Co., Ltd. (000931.SZ) Has 34 Products Included in National Reimbursement Drug List","media":"Stock News","content":"<p>Beijing Centergate Technologies (Holding) Co., Ltd. (000931.SZ) announced that some drugs developed by its subsidiaries have been included in the National Reimbursement Drug List (NRDL) for 2025. The company's wholly-owned subsidiary, Beijing Zhongguancun Sihuan Pharmaceutical Development Co., Ltd. (Sihuan Pharmaceutical), along with its controlled subsidiaries—Beijing Huasu Pharmaceutical Co., Ltd. (Beijing Huasu), Shandong Huasu Pharmaceutical Co., Ltd. (Shandong Huasu), and Duoduo Pharmaceutical Co., Ltd. (Duoduo Pharmaceutical)—have collectively secured 34 in-production products in the 2025 NRDL.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Beijing Centergate Technologies (Holding) Co., Ltd. (000931.SZ) Has 34 Products Included in National Reimbursement Drug List</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nBeijing Centergate Technologies (Holding) Co., Ltd. (000931.SZ) Has 34 Products Included in National Reimbursement Drug List\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1036600163\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/b3bf6d02ad1a6e9e7377eebbb162346a);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Stock News </p>\n<p class=\"h-time\">2025-12-12 16:24</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Beijing Centergate Technologies (Holding) Co., Ltd. (000931.SZ) announced that some drugs developed by its subsidiaries have been included in the National Reimbursement Drug List (NRDL) for 2025. The company's wholly-owned subsidiary, Beijing Zhongguancun Sihuan Pharmaceutical Development Co., Ltd. (Sihuan Pharmaceutical), along with its controlled subsidiaries—Beijing Huasu Pharmaceutical Co., Ltd. (Beijing Huasu), Shandong Huasu Pharmaceutical Co., Ltd. (Shandong Huasu), and Duoduo Pharmaceutical Co., Ltd. (Duoduo Pharmaceutical)—have collectively secured 34 in-production products in the 2025 NRDL.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK0028","symbol_name":"国家队","start_time":0,"source_url":"","article_id":"1108769445","we_media_id":"1036600163","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1108769445","pubTimestamp":1765527852,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Stock News","introduction":"Global Stock News First-Time Broadcast","home_visible":1,"id":"1036600163","head_image":"https://community-static.tradeup.com/news/b3bf6d02ad1a6e9e7377eebbb162346a"},"summary":"Beijing Centergate Technologies (Holding) Co., Ltd. (000931.SZ) announced that some drugs developed by its subsidiaries have been included in the National Reimbursement Drug List (NRDL) for 2025. The...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"BK0028":"国家队","000931":"中关村","BK0239":"医药制造","BK0075":"新三板","BK0178":"特色小镇"},"translate_title":"北京中捷科技（控股）股份有限公司（000931.SZ）有34个产品纳入国家报销药品目录","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"000931":1},"content_text":"Beijing Centergate Technologies (Holding) Co., Ltd. (000931.SZ) announced that some drugs developed by its subsidiaries have been included in the National Reimbursement Drug List (NRDL) for 2025. The company's wholly-owned subsidiary, Beijing Zhongguancun Sihuan Pharmaceutical Development Co., Ltd. (Sihuan Pharmaceutical), along with its controlled subsidiaries—Beijing Huasu Pharmaceutical Co., Ltd. (Beijing Huasu), Shandong Huasu Pharmaceutical Co., Ltd. (Shandong Huasu), and Duoduo Pharmaceutical Co., Ltd. (Duoduo Pharmaceutical)—have collectively secured 34 in-production products in the 2025 NRDL.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"productRelease","news_rank":0,"symbols":[],"gpt_button":1,"need_auth":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.35.11","shortVersion":"4.35.11","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1108769445","isCrawlerRequest":true}